BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6705330)

  • 1. Thyroid damage--after treatment for Hodgkin's disease.
    Wrigley PF; Sutcliffe SB
    Clin Oncol; 1984 Mar; 10(1):91-2. PubMed ID: 6705330
    [No Abstract]   [Full Text] [Related]  

  • 2. Late complications of Hodgkin's disease management.
    Young RC; Bookman MA; Longo DL
    J Natl Cancer Inst Monogr; 1990; (10):55-60. PubMed ID: 2189477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: Hodgkin's disease. Five years' experience of a combined haemic-lymphatic clinic.
    Ewing DP; Rozenberg MC; Freedman A; Grace CS; Lam-Po-Tang PR
    Med J Aust; 1974 Jul; 2(4):128-32. PubMed ID: 4419384
    [No Abstract]   [Full Text] [Related]  

  • 4. [Late complications after treatment of Hodgkin's disease].
    Lund MB; Kongerud J; Boe J; Ihlen H; Forfang K; Abrahamsen AF; Nome O
    Tidsskr Nor Laegeforen; 1999 Mar; 119(7):933-7. PubMed ID: 10210953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of long-term side effects--in particular induced leukemias following treatment for Hodgkin's disease.
    De Renzis C; Cellini N; Ausili Cefaro GP; Mantini G; Parisi S; Smaniotto D
    Rays; 1986; 11(2):109-13. PubMed ID: 3602444
    [No Abstract]   [Full Text] [Related]  

  • 6. Thyroid damage--after treatment for Hodgkin's disease.
    Dobbs HJ
    Clin Oncol; 1983 Mar; 9(1):51-6. PubMed ID: 6342893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute non-lymphoblastic leukosis as a second neoplasm in Hodgkin's disease].
    Díaz Pérez MA; Zamora Auñón P; Escobar Alvarez Y; García de Parecdes ML
    Med Clin (Barc); 1985 Feb; 84(4):167. PubMed ID: 3982119
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutagenesis after therapy for Hodgkin's disease.
    Kelsey KT; Caggana-Aviles M; Mauch P; Coleman CN; Shulman LN; Liber HL
    Hematol Oncol Clin North Am; 1993 Apr; 7(2):353-67. PubMed ID: 8468270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tolerance and results of treatment of Hodgkin's disease].
    Krahulová M; Pisarcíková M; Adam Z; Vorlícek J; Hejlová N; Mayer J; Spelda S
    Vnitr Lek; 1995 Apr; 41(4):243-7. PubMed ID: 7762189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thyroid diseases following therapy for Hodgkin's disease].
    Emrich D; Hilgers R
    Dtsch Med Wochenschr; 1993 Jan; 118(4):125-6. PubMed ID: 8428559
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute leukemia after the treatment of Hodgkin's disease.
    Henry-Amar M; Dietrich PY
    Hematol Oncol Clin North Am; 1993 Apr; 7(2):369-87. PubMed ID: 8468271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant illness in patients treated for Hodgkin's disease.
    Bookman MA; Longo DL
    Cancer Treat Rev; 1986 Jun; 13(2):77-111. PubMed ID: 3527412
    [No Abstract]   [Full Text] [Related]  

  • 14. [Late treatment related complications of Hodgkin's disease].
    Henry-Amar M; Gisselbrecht C
    Rev Prat; 1998 May; 48(10):1092-7. PubMed ID: 9781154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hodgkin's disease.
    Longo DL; Banks PM; Hoppe RT
    Rev Invest Clin; 1994 Apr; Suppl():73-83. PubMed ID: 7886314
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thyroid complications in Hodgkin's disease patients treated with radiotherapy and chemotherapy].
    Serrano JC; Contreras K; Insausti L; Figueroa L; Acquatella G
    Sangre (Barc); 1999 Dec; 44(6):496-7. PubMed ID: 10822773
    [No Abstract]   [Full Text] [Related]  

  • 17. [Low grade non-Hodgkin's lymphoma after combined therapy for Hodgkin's disease].
    Raya Sánchez JM; González Brito G; Hernández Nieto L; Brito Barroso ML; Alvarez Argüelles H; Jorge Hernández JA; Martín Herrera A
    Sangre (Barc); 1994 Dec; 39(6):461-4. PubMed ID: 7855699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late complications of therapy of Hodgkin's disease: prevention and management.
    Ng AK; Mauch PM
    Curr Hematol Rep; 2004 Jan; 3(1):27-33. PubMed ID: 14695846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid dysfunction in children receiving neck irradiation for Hodgkin's disease.
    Atahan IL; Yildiz F; Ozyar E; Uzal D
    Radiat Med; 1998; 16(5):359-61. PubMed ID: 9862158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid volume is progressively reduced as a sequela of neck irradiation for childhood Hodgkin's disease.
    Bossi G; Larizza D; Sommaruga G; Corbella F; Klersy C; Aricò M
    Haematologica; 1998 Aug; 83(8):754-6. PubMed ID: 9793265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.